New York State Common Retirement Fund’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-142,700
Closed -$6.52M 3105
2017
Q4
$6.52M Hold
142,700
0.01% 1146
2017
Q3
$6.4M Buy
142,700
+5,000
+4% +$170K 0.01% 1126
2017
Q2
$4.12M Buy
137,700
+10,999
+9% +$271K 0.01% 1349
2017
Q1
$2.81M Buy
126,701
+1
+0% +$21 ﹤0.01% 1491
2016
Q4
$2.39M Hold
126,700
﹤0.01% 1596
2016
Q3
$3.8M Buy
126,700
+2,835
+2% +$88.2K 0.01% 1334
2016
Q2
$4.76M Buy
123,865
+96,365
+350% +$4M 0.01% 1247
2016
Q1
$1.05M Hold
27,500
﹤0.01% 1917
2015
Q4
$1.21M Hold
27,500
﹤0.01% 1865
2015
Q3
$1.12M Buy
27,500
+7,325
+36% +$321K ﹤0.01% 1881
2015
Q2
$1.08M Buy
+20,175
New +$1.07M ﹤0.01% 2137

Other funds holding JUNO

New York State Common Retirement Fund's JUNO Position: Q1 2018 in Review

New York State Common Retirement Fund sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 142,700 shares — an estimated $6.52M sold.

New York State Common Retirement Fund first reported a position in JUNO in Q2 2015 and held it in 11 quarters. The position peaked at $6.52M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • New York State Common Retirement Fund reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • New York State Common Retirement Fund sold 142,700 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $6.52M.
  • New York State Common Retirement Fund first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 11 quarters.
  • New York State Common Retirement Fund's Juno Therapeutics, Inc. position peaked at $6.52M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on New York State Common Retirement Fund's 13F filing for Q1 2018, filed 10 May 2018.